QA: Paratek Pharmaceuticals Inc. in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178711_2017_Paratek_Pharmaceuticals_Inc.pdf

Logs

Graph

Absolute values for 0001178711, Paratek Pharmaceuticals Inc.

  xvar xval
0 AssetsCurrent 132,100,000
1 IntangibleAssetsNetIncludingGoodwill 1,844,000
2 PropertyPlantAndEquipmentNet 1,188,000
3 remainder_Assets 600,000
4 LiabilitiesCurrent 20,412,000
5 LiabilitiesNoncurrent 43,073,000
6 remainder_Liabilities 655,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 26,400,000
9 ResearchAndDevelopmentExpense 83,460,000
10 remainder_Expenses 2,878,000
11 remainder_Revenues 29,000
12 remainder_NetIncome 1,073,000
13 remainder_ComprehensiveNetIncome -16,000
  yvar yval
0 Assets 135,732,000
1 Liabilities 64,140,000
2 Expenses 112,738,000
3 Revenues 29,000
4 StockholdersEquity 71,592,000
5 NetIncome -111,636,000
6 ComprehensiveNetIncome -111,644,000
7 BaseVar 156,864,000
8 EconomicCapitalRatio 0.115

Edgar->Model Mapping

Feature Distribution